Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Loading...

Wednesday 13 January 2021

Investorideas.com - Psychedelic Stock News: Neonmind (CSE: NEON) Engages Dr. C. Laird Birmingham To Develop Protocols For Phase 2 Clinical Trial Using Psilocybin To Treat Obesity

Investorideas.com - Psychedelic Stock News: Neonmind (CSE: NEON) Engages Dr. C. Laird Birmingham To Develop Protocols For Phase 2 Clinical Trial Using Psilocybin To Treat Obesity
-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB) : You can't hold a good weed stock down (Nasdaq: CG...